The developers of a coronavirus vaccine in Britain yesterday claimed success after mass testing, as the United States announced plans to give jabs to 20 million people before the end of the year to combat surging infections. Interim data suggests 70% protection, but the researchers said the figure may be as high as 90% by tweaking the dose, according to AstraZeneca and Oxford